Skip to content
Open access

CVMI-age quantifies multidimensional cardiovascular aging and predicts cardiovascular events: a Chinese community-based cohort study

Oct 2026 · European Heart Journal · 0 citations

Abstract

Cardiovascular (CV) aging is a complex biological process driven by hemodynamic stress, metabolic dysregulation, and chronic inflammation. Traditional vascular aging models relying solely on arterial stiffness often fail to capture the systemic immuno-metabolic burden, leaving a gap in quantifying the residual CV risk in the general population. This study aims to construct a composite Cardiovascular-Metabolic-Inflammatory Age (CVMI-Age), identify distinct aging phenotypes and determine their independent predictive value for major adverse CV events (MACE) over standard risk scores and simple stiffness-based metrics. 8,096 participants without CV disease were analyzed from a Chinese community-based cohort. CVMI-Age was constructed using GAM and LASSO regression. Predictors included: (1) Vascular: brachial-ankle pulse wave velocity (baPWV), carotid intima-media thickness, ankle-brachial index, and blood pressure; (2) Metabolic: triglyceride-glucose index, lipid accumulation product index, cardiometabolic index, atherogenic index of plasma, and weight-adjusted-waist index; and (3) Inflammatory: systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and neutrophil-to-HDL ratio. ΔCVMI-Age was defined as the residual obtained from a regression of CVMI-Age on chronological age. Participants were stratified into Decelerated (DCA, <10th percentile), Normal (NCA, 10th-90th), and Accelerated (ACA, >90th) CV aging phenotypes. The endpoint was MACE, comprising CV mortality, non-fatal stroke, and non-fatal myocardial infarction. Statistical analyses included restricted cubic splines (RCS), Kaplan-Meier curves, Cox proportional hazard models, and reclassification metrics (C-statistic, NRI and IDI). Mean age was 56.6 ± 8.9 years, and 5,226 were female (64.2%). Over a median follow-up of 9.31 years, 815 (10.1%) participants experienced MACE. RCS analysis revealed a J-shaped non-linear association between ΔCVMI-Age and MACE (P <0.001, P for non-linear <0.001). Kaplan-Meier curves showed significant divergence in cumulative MACE incidence among CVMI-Age phenotypes (Log-rank P<0.001). After adjusting for age, sex, and the China-PAR CV risk score, the ACA phenotype was independently associated with increased MACE risk (HR 1.70, 95% CI 1.42–2.03) compared with NCA, while DCA was protective (HR 0.71, 95% CI 0.54–0.93). Notably, the addition of ΔCVMI-Age significantly improved risk discrimination and reclassification beyond the combined model incorporating both China-PAR and baPWV-derived age (C-statistic increase 0.0033; NRI 5.56%; IDI 0.37%; all P<0.05). CVMI-Age is a potential biological aging marker integrating vascular structure with systemic immuno-metabolic profiles. The ACA phenotype identifies high-risk individuals with hidden burdens missed by traditional scores, offering significant incremental value for risk stratification.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.